Literature DB >> 3708875

Management of cranial diabetes insipidus with oral desmopressin (DDAVP).

D Cunnah, G Ross, G M Besser.   

Abstract

The effect of oral administration of desmopressin (DDAVP) solution was investigated in six patients with cranial diabetes insipidus of varying aetiology. All patients experienced a prompt and prolonged antidiuresis. Nine patients have been managed with oral DDAVP tablets for up to 5 months and all preferred this route of administration to intranasal application using a rhinyle. Oral DDAVP gives excellent and convenient control in cranial diabetes insipidus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3708875     DOI: 10.1111/j.1365-2265.1986.tb03265.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  4 in total

1.  Comparison of intranasal and oral desmopressin for nocturnal enuresis.

Authors:  A Fjellestad-Paulsen; S Wille; A S Harris
Journal:  Arch Dis Child       Date:  1987-07       Impact factor: 3.791

2.  Oral desmopressin in neonatal diabetes insipidus.

Authors:  S M Stick; P R Betts
Journal:  Arch Dis Child       Date:  1987-11       Impact factor: 3.791

3.  Management of diabetes insipidus in children.

Authors:  Garima Mishra; Sudha Rao Chandrashekhar
Journal:  Indian J Endocrinol Metab       Date:  2011-09

4.  The Role of Desmopressin in the Management of Severe, Hypovolemic Hyponatremia: A Single-Center, Comparative Analysis.

Authors:  Frank L Ward; Sheldon W Tobe; David M J Naimark
Journal:  Can J Kidney Health Dis       Date:  2018-03-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.